| Value | ₹5.50 Cr |
|---|
BSE filing, NSE: AAREYDRUGS. Summary written from the filing by ALFA Finder's alert engine.
Aarey Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹110.84
- Market cap
- ₹314.3 Cr
- Revenue (annual)
- ₹472.3 Cr
- Net profit (annual)
- ₹3.97 Cr
- P/E (TTM)
- 75.3×Sector 48.7×
- Promoter holding
- 41.45%+3.74% QoQ
- FII holding
- 4.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarey Drugs & Pharmaceuticals Ltd
All →Aarey Drugs & Pharmaceuticals Other Announcement
Aarey Drugs & Pharmaceuticals Ltd filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulations.
Aarey Drugs & Pharmaceuticals Capital Structure Change
Promoter and promoter group of Aarey Drugs & Pharmaceuticals Ltd acquired 23.70 lakh shares following the conversion of warrants. The acquisition increased their stake by 4.81%.
- Promoter stake change
- +4.81%
Aarey Drugs & Pharmaceuticals Capital Structure Change
Aarey Drugs allotted equity shares to promoters following the conversion of 23,40,000 warrants. This capital structure change increases the promoters' equity stake in the company.
- Value
- ₹11.20 Cr
Aarey Drugs & Pharmaceuticals Annual General Meeting
Aarey Drugs & Pharmaceuticals Ltd. held its 36th Annual General Meeting on September 30, 2026, to conduct business including financial statement adoption and director re-appointment.
Aarey Drugs & Pharmaceuticals Capital Structure Change
Aarey Drugs & Pharmaceuticals Ltd approved the allotment of 11,50,000 equity shares following the conversion of warrants. The allotment aggregate value is Rs. 7.34 Crore.
- Value
- ₹7.34 Cr
Aarey Drugs & Pharmaceuticals Other Announcement
Aarey Drugs & Pharmaceuticals Ltd filed its quarterly shareholding pattern. This is a routine regulatory compliance disclosure regarding the company's equity distribution.
Other capital structure change announcements
All →Sona BLW Precision Forgings Capital Structure Change
ICICI Prudential Mutual Fund disclosed an open-market sale of about 122.99 million Sona BLW shares. Its stake fell from 7.06% to 5.05% over the relevant period.
DCM Shriram Industries Capital Structure Change
Mugi Constructions and two PACs bought 45,94,000 DCM Shriram shares in the open market, reaching 5.281% of equity. The cross-5% Reg 29(1) disclosure signals a non-promoter accumulation.
MRC Agrotech Capital Structure Change
Wordexx Ventures Pvt Ltd, a non-promoter, sold 5,84,823 MRC Agrotech shares in open market, reducing its stake from 10.62% to 8.75%. No transaction value disclosed.
Natco Pharma Capital Structure Change
Natco Pharma allotted 5,86,666 equity shares to promoter Venkaiah Chowdary Nannapaneni via its rights issue, valued at ~₹44 Crore. This lifts his stake to 14.60%.
- Value
- ₹44.00 Cr
RGF Capital Markets Capital Structure Change
Nishad J. Shah and PACs acquired 2,54,80,900 RGF Capital Markets shares (16.98%) off-market via SPA. The non-promoter buy will trigger an open offer before promoter classification.
Suvidhaa Infoserve Capital Structure Change
Suvidhaa Infoserve Ltd approved the terms for its Rights Issue, including a price of ₹1.50 per share. The issue size is ₹11.80 Crore.
- Value
- ₹11.80 Cr